Mesothelin (MSLN) is a cell surface protein highly expressed in several types of malignant tumors, such as malignant mesothelioma, ovarian cancer, pancreatic adenocarcinoma, and lung adenocarcinoma, sometimes in association with increased tumor aggressiveness and poor clinical outcome. The gene discussed is MSLN; the disease is pancreatic adenocarcinoma.